ArticleBreast cancer research and treatment2020
The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer.
Anouk K M Claessens et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.